Paclitaxel Fresenius Kabi Deutschland

Paclitaxel, the active ingredient in Paclitaxel Fresenius Kabi Deutschland, is a taxane presented as a strength/form for intravenous use. It treats various solid tumours and is administered to adult oncology patients. GNH USA supplies Paclitaxel Fresenius Kabi Deutschland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

GNH USA supplies Paclitaxel Fresenius Kabi Deutschland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Paclitaxel is a taxane chemotherapy agent used in the treatment of several solid tumour types.

- Breast cancer: improves survival by inhibiting tumor cell proliferation. - Non‑small cell lung cancer: reduces tumor burden and extends progression‑free survival. - Ovarian cancer: enhances response rates when combined with platinum‑based regimens. - Kaposi sarcoma: controls disease progression in HIV‑related cases. - Gastric cancer: contributes to disease control in advanced stages.

Paclitaxel           …   …  …  … …  …  … … … … …  …  …